Your Search Returned 136 tagged news reports
February 2014 Freshwater Anglers find DOC's 1080 response disingenuous' "The comments made by Kevin O'Connor, DOC Deputy Director General, in response to the Federation's call for robust research on the risks of secondary poisoning of trout by mice
announced last summer would be discontinued on Feb. 20 because it wasn't earning the company enough money. That harsh reality has begun to sink in for those who adamantly oppose GSK's decision to scrap this effective, safe, FDA-approved therapy for
Forest Laboratories Inc. swung to a fiscal third-quarter profit, as sales of its next generation of drugs continued to grow. For the full fiscal ending March 31, the company raised its per-share earnings estimate to $1.25 to $1.35, from its October
They're up for treating patient who have already had one cardiac event, which is still a good-sized market.
Jan 13, 2014 Antidepressants are wildly popular in the United States, where one in 10 people take them. The problem is that they sometimes cause what's called suicidal ideationthoughts of suicide. A new genetic test may help doctors identify those
She's still passed all her drug tests and remains Prozac free. Barbara graduated from the University of Pittsburgh in her hometown...She is single and has lived in Fort Lauderdale for the past decade.
Shares Crashed Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...So what: According to Onconova's press release,
Researchers at the University of Bologna said Thursday they were able to cure the effects of Down syndrome in mice while they were still in the womb using Prozac. The results of the study were published in the neuroscience magazine Brain. Led by
The lawsuit of two Texas death row inmates, claiming they will be executed with drugs of unknown potency, was dismissed by a federal judge in Houston. Thomas Whitaker, Perry Williams and Michael Yowell filed the suit in October, saying the Texas
Now that the FDA has told them to take the drug off the market completely, it was clear what was going to happen. Happen it has: the company is laying off a large part of its workforce. It's very much in doubt whether Inclusig will ever come back.